SCPDG Announces our May 12, 2026 Meeting

Presentation 1 (15 Min)

Disparities in Utilization of Diabetes Complications-related Preventive Services Among U.S. Adults with Diabetes: Evidence from the Medical Expenditure Panel Survey (MEPS)

Presented by

Mr.

Chapman University, Department of Ph*rm*cy

Abstract: Diabetes-related complications such as neuropathy, retinopathy, nephropathy, and foot ulcers are largely preventable through the timely delivery of recommended preventive services. Despite established clinical guidelines, evidence suggests that disparities in the utilization of preventive services for diabetes complications persist across sociodemographic groups in the United States.

A cross-sectional design, analyzing pooled data from the 2018–2022 Medical Expenditure Panel Survey (MEPS).

Adults aged ≥18 years who reported a diagnosis of diabetes were included. The primary outcome was receipt of all five recommended diabetes preventive services (≥2 A1c tests, eye examination, foot examination, cholesterol check, and influenza vaccination).

Among adults with diabetes, only 37.7% received all five recommended preventive services. Education level, race/ethnicity, insurance category, sex, and age were significant predictors of receiving all five recommended diabetes preventive services (Adjusted Wald F p < .05).

Persistent disparities by education, insurance status, and race/ethnicity highlight inequities in access to high-quality diabetes care.

Presentation 2 (45 Min)

Unified Clinical Intelligence — An AI Platform for End-to-End Clinical Development

Presented By

Mr. Veeps Piravi

Co-Founder, InnovoCommerce

Abstract: Clinical research organizations face a structural challenge: trial design,execution, and monitoring operate in silos, driving reactive decisions and costly rework. A new class of purpose-built clinical AI platforms addresses this by spanning the full study lifecycle—from preclinical research and protocol authoring to study startup, governance, site engagement, and closeout.

Unlike retrofitted tools, these platforms use Retrieval-Augmented Generation (RAG) to ground outputs in organizational knowledge and external sources such as literature, registries, and real-world data. The impact is threefold: faster, standardized document workflows with built-in compliance; earlier, data-driven protocol design that reduces amendments; and a unified intelligence layer across EDC, CTMS, and eTMF systems enabling proactive risk detection.

Beyond efficiency, the value compounds—better protocols improve enrollment, fewer amendments reduce delays, and embedded compliance lowers inspection risk. This marks a shift from AI as a productivity tool to AI as an institutional intelligence layer across clinical development.

Date: Tuesday, May 12, 2026

Location: Waters Technologies District Office, 3540 Howard Way, Suite 100, Costa Mesa, CA 92626

Agenda: This is a hybrid event. Check-in and Networking from 4:00-4:30 PM PT. Presentation and Discussion will be from 4:30-6:00 PM PT. Zoom login will open at 4:15 PM PT. There is no charge for on-site attendance as there will not be any refreshments for this event. Virtual attendance is always free.

Registration: Please register by 5:00 PM PDT, Friday, May 8.

Important note for virtual attendance: You must register to receive an emailed Zoom link for virtual attendance. You will receive the Zoom link after registration closes at 5:00 PM PDT on Friday, May 8th.

Know what’s Happening Next — before everyone else does.

Get App

Host or Publisher Southern CA Pharmaceutical Discussion Group